Arabesque Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,143
Closed -$4.81M 79
2022
Q4
$4.81M Buy
13,143
+5,211
+66% +$1.85M 1.63% 4
2022
Q3
$2.56M Sell
7,932
-901
-10% -$285K 1.25% 12
2022
Q2
$2.86M Sell
8,833
-5,333
-38% -$1.6M 1.51% 6
2022
Q1
$4.06M Buy
14,166
+5,291
+60% +$1.36M 1.41% 10
2021
Q4
$2.45M Buy
8,875
+1,782
+25% +$452K 0.71% 61
2021
Q3
$1.64M Buy
7,093
+1,359
+24% +$335K 0.55% 92
2021
Q2
$1.32M Buy
+5,734
New +$1.15M 0.56% 74
2020
Q3
Sell
-19,644
Closed -$3.23M 84
2020
Q2
$3.23M Buy
+19,644
New +$3.02M 2.18% 15
2020
Q1
Sell
-9,519
Closed -$1.25M 91
2019
Q4
$1.25M Sell
9,519
-22,910
-71% -$2.66M 0.48% 86
2019
Q3
$3.63M Buy
32,429
+3,972
+14% +$442K 1.67% 16
2019
Q2
$3.15M Buy
28,457
+452
+2% +$53.2K 1.44% 23
2019
Q1
$3.63M Sell
28,005
-941
-3% -$114K 1.87% 6
2018
Q4
$3.35M Buy
+28,946
New +$3.23M 3.28% 1

Other funds holding LLY

Arabesque Asset Management's LLY Position: Q1 2023 in Review

Arabesque Asset Management sold out of Eli Lilly (LLY) in Q1 2023, closing a stake of 13,143 shares — an estimated $4.81M sold.

Arabesque Asset Management first reported a position in LLY in Q4 2018 and held it in 13 quarters. The position peaked at $4.81M in Q4 2022. 2,614 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

  • Arabesque Asset Management reported no remaining Eli Lilly position as of Q1 2023 after selling out during the quarter.
  • Arabesque Asset Management sold 13,143 Eli Lilly shares in Q1 2023, an estimated $4.81M.
  • Arabesque Asset Management first reported a position in Eli Lilly in Q4 2018 and held it in 13 quarters.
  • Arabesque Asset Management's Eli Lilly position peaked at $4.81M in Q4 2022.
  • 2,614 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on Arabesque Asset Management's 13F filing for Q1 2023.